{"id":"nephrotrans","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Nephrotrans","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:27:44.726370+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:27:52.120895+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Nephrotrans","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:27:52.891472+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-27T23:35:01.463Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:27:55.160953+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03301558","phase":"PHASE2","title":"The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients","status":"WITHDRAWN","sponsor":"Prim. Priv. Doz. Dr. Daniel Cejka","startDate":"2026-01-01","conditions":"Kidney Transplant; Complications","enrollment":""},{"nctId":"NCT03102996","phase":"PHASE4","title":"Preserve-Transplant Study","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-06-12","conditions":"Acidosis, Renal Insufficiency, Kidney Transplantation","enrollment":240},{"nctId":"NCT00130598","phase":"PHASE2, PHASE3","title":"PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2005-06","conditions":"Kidney Failure, Acute","enrollment":258}],"_emaApprovals":[],"_faersSignals":[{"count":30,"reaction":"ANAEMIA"},{"count":19,"reaction":"GENERAL PHYSICAL HEALTH DETERIORATION"},{"count":17,"reaction":"BLOOD CREATININE INCREASED"},{"count":16,"reaction":"HYPERKALAEMIA"},{"count":15,"reaction":"DYSPNOEA"},{"count":15,"reaction":"HAEMOGLOBIN DECREASED"},{"count":14,"reaction":"ASTHENIA"},{"count":12,"reaction":"CARDIAC FAILURE"},{"count":12,"reaction":"OEDEMA"},{"count":12,"reaction":"RENAL FAILURE"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Nephrology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Nephrotrans","genericName":"Nephrotrans","companyName":"University of Zurich","companyId":"university-of-zurich","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:27:55.160953+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}